WEST PHARMACEUTICAL SERVICES INC (WST)
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Instruments & Supplies
West Pharmaceutical Services, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 70.38M shares outstanding
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
It serves pharmaceutical, diagnostic, and medical device companies.
The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Leadership
Annette F. Favorite
Chief Human Resources Officer & Senior Vice President
ERIC M. GREEN
Non-Independent Chair of the Board, President & Chief Executive Officer
Robert W. McMahon
Senior Vice President & Chief Financial Officer
Shane A. Campbell
SVP & Chief Proprietary Segment Officer
Employees
11K+
Country
US
Sector
Healthcare
Website
westpharma.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 44 | $16.3K | Sep 30, 2026 | |
| Sr. VP & Chief HR Officer | Sale | 2.5K | $921.3K | Sep 15, 2026 | |
| Sr. VP & Chief HR Officer | Option Exercise | 2.5K | $226.3K | Sep 15, 2026 | |
| Sr. VP & Chief HR Officer | Option Exercise | 2.5K | -- | Sep 15, 2026 | |
| Sr. VP & Chief HR Officer | Option Exercise | 2.5K | $224.1K | Sep 14, 2026 | |
| Sr. VP & Chief HR Officer | Option Exercise | 2.5K | -- | Sep 14, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 6.7M | 9.5% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Apr 2025 | 6.1M | 8.6% | 13G |
VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | 6.6% | 13F |
VANGUARD PORTFOLIO MANAGEMENT LLC | 4.0M | 5.7% | 13F |
FMR LLC | 3.6M | 5.1% | 13F |
STATE STREET CORP | 3.3M | 4.8% | 13F |
Artisan Partners Limited Partnership | 2.4M | 3.4% | 13F |
Bank of New York Mellon Corp | 2.0M | 2.9% | 13F |
GENERATION INVESTMENT MANAGEMENT LLP | 2.0M | 2.9% | 13F |
GEODE CAPITAL MANAGEMENT, LLC | 1.9M | 2.7% | 13F |
Insiders
- HAUGEN JANET BRUTSCHEADirector
- Favorite Annette FSr. VP & Chief HR Officer
- Lagarde MichelPresident and CEO
- McMahon Robert W.SVP & Chief Financial Officer
- Campbell Shane AldenSVP, Proprietary Segment
- Michels Douglas ADirector
- Pucci PaoloDirector
- Joseph MollyDirector
- Feehery William FDirector
- BUTHMAN MARK ADirector
based on 70.38M shares outstanding
30d Avg
513.63K
60d Avg
557.10K
90d Avg
553.64K